The predictors of treatment adherence among hypertensive patients with cost-free access

The level and predictors of medication adherence have not been given attention among populations for whom the cost of treatment is not a concern, especially in the Ghanaian healthcare setting. This study compared generalised linear models to determine the factors associated with adherence to treatment among hypertensive patients with a workplace policy that offers cost-free access in Ghana. We conducted a cross-sectional descriptive study to investigate the level of adherence and factors that influence practice among hypertensive patients with cost-free access to treatment. A total of 254 respondents were conveniently sampled and administered a questionnaire. The predictors of treatment adherence were assessed using Bivariate and generalised linear models (logistic and complementary log-log regression models). The complementary log-log regression model outperformed the logistic regression model in fitting the relationships in the data, by reporting lower AIC and BIC, and higher Nagelkerke and Cox and Snell pseudo-R-squared values. Most (88.9%) respondents scored low adherence, and only 11.1% adhered to treatment. The factors that affect adherence to hypertension medication included age (ARR = 8.58, 95%CI 1.23-83.28, p-value = 0.031), sex (ARR = 0.19, 95%CI 0.03-0.91, p-value = 0.042), location (ARR = 10.78, 95%CI 2.01-79.76, p-value = 0.007), busy schedule (ARR = 0.03, 95%CI 0.00-0.30, p-value = 0.016), time spent (ARR = 0.05, 95%CI 0.00-0.28, p-value = 0.002) and accessibility (ARR = 17.89, 95%CI 4.03-112.38, p-value < 0.001). The high level of non-adherence to treatment among patients, even when the cost of treatment is not a barrier, could contribute to overall treatment outcomes. Despite cost-free access, adherence remains low, highlighting the need for further investigation into non-cost barriers affecting treatment compliance. In addition, there is a need to design and implement measures to improve adherence among patients with hypertension in the country.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-01-30
DOI
https://doi.org/10.1038/s41598-026-36702-z
Primary Topic
Medication Adherence and Compliance
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The predictors of treatment adherence among hypertensive patients with cost-free access

David Adedia, Robert N. Quaicoe, Vivian F. Boateng, Joyce Gbeamir et al.
Scientific Reports
Medication Adherence and Compliance
article

The predictors of treatment adherence among hypertensive patients with cost-free access

David Adedia, Robert N. Quaicoe, Vivian F. Boateng, Joyce Gbeamir, Felix Kwasi Nyande, Kennedy Diema Konlan, Veronica Dankwah, Linda Serwaa Asiamah
article en

Abstract

The level and predictors of medication adherence have not been given attention among populations for whom the cost of treatment is not a concern, especially in the Ghanaian healthcare setting. This study compared generalised linear models to determine the factors associated with adherence to treatment among hypertensive patients with a workplace policy that offers cost-free access in Ghana. We conducted a cross-sectional descriptive study to investigate the level of adherence and factors that influence practice among hypertensive patients with cost-free access to treatment. A total of 254 respondents were conveniently sampled and administered a questionnaire. The predictors of treatment adherence were assessed using Bivariate and generalised linear models (logistic and complementary log-log regression models). The complementary log-log regression model outperformed the logistic regression model in fitting the relationships in the data, by reporting lower AIC and BIC, and higher Nagelkerke and Cox and Snell pseudo-R-squared values. Most (88.9%) respondents scored low adherence, and only 11.1% adhered to treatment. The factors that affect adherence to hypertension medication included age (ARR = 8.58, 95%CI 1.23-83.28, p-value = 0.031), sex (ARR = 0.19, 95%CI 0.03-0.91, p-value = 0.042), location (ARR = 10.78, 95%CI 2.01-79.76, p-value = 0.007), busy schedule (ARR = 0.03, 95%CI 0.00-0.30, p-value = 0.016), time spent (ARR = 0.05, 95%CI 0.00-0.28, p-value = 0.002) and accessibility (ARR = 17.89, 95%CI 4.03-112.38, p-value < 0.001). The high level of non-adherence to treatment among patients, even when the cost of treatment is not a barrier, could contribute to overall treatment outcomes. Despite cost-free access, adherence remains low, highlighting the need for further investigation into non-cost barriers affecting treatment compliance. In addition, there is a need to design and implement measures to improve adherence among patients with hypertension in the country.

Scientific ReportsVol. 16(1)
University of Health and Allied Sciences (GH)
Openalex Percentile: Top 74%
Medication Adherence and Compliance
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.